Drug Name: Posluma
Indications: To use with positron emission tomography imaging in certain patients with prostate cancer.
Active Ingredient: Flotufolastat F 18
Company: Blue Earth Diagnostics Ltd.
Approval Date: 5/25/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216023s000lbl.pdf